APOB and metabolic dysfunction-associated steatotic liver disease: Decreased plasma levels of apob in patients with non-alcoholic fatty liver disease (NAFLD) impairs the anti-inflammatory ability, and the impaired anti-inflammatory activity is independently correlated with NAFLD [26].